Recent Research on Combination of Radiotherapy with Targeted Therapy or Immunotherapy in Head and Neck Squamous Cell Carcinoma: A Review for Radiation Oncologists
Radiotherapy plays an important role of managing head and neck squamous cell carcinoma (HNSCC). Concurrent radiotherapy with radiosensitizing cisplastin chemotherapy is the standard of care (SOC) for non-operable locally advanced HNSCC. Cetuximab, a monoclonal antibody of epidermal growth factor rec...
Guardado en:
Autores principales: | Daniel Tao Xing, Richard Khor, Hui Gan, Morikatsu Wada, Tai Ermongkonchai, Sweet Ping Ng |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
MDPI AG
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/9e7f46bbe9ad42db9979acc800d8f515 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Molecular Response to Combined Molecular- and External Radiotherapy in Head and Neck Squamous Cell Carcinoma (HNSCC)
por: Treewut Rassamegevanon, et al.
Publicado: (2021) -
Bibliometric Analysis of the Top-Cited Publications and Research Trends for Stereotactic Body Radiotherapy
por: Yanhao Liu, et al.
Publicado: (2021) -
Combined treatment of non‐small cell lung cancer using radiotherapy and immunotherapy: challenges and updates
por: Shijie Shang, et al.
Publicado: (2021) -
Antigen-Capturing Mesoporous Silica Nanoparticles Enhance the Radiation-Induced Abscopal Effect in Murine Hepatocellular Carcinoma Hepa1-6 Models
por: Kyungmi Yang, et al.
Publicado: (2021) -
Osteoradionecrosis in a Patient Submitted to Head and Neck Radiotherapy: A Case Report
por: Ferreira,Karla Daniella Malta, et al.
Publicado: (2019)